Concepedia

Jordi Galván

JG

Statistics

Publications

6

Citations

321

H-Index

6

Active since

2003

Affiliations

Almirall (Spain)(Current)

Gebro Pharma (Spain)

Universitat Autònoma de Barcelona

Clinica Universidad de Navarra

Jordi Galván is an author at Almirall (Spain) specializing in medicine, clinical pharmacology, and pharmacotherapy.

ORCID

Publications per year

2003–2024

6

Publications

6

Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial

Bianca Maria Piraccini, Ulrike Blume‐Peytavi, F. Scarci et al. · Journal of the European Academy of Dermatology and Venereology · 2021 · 157 citations · Full text

, , +17

Observational, retrospective study of the effectiveness of 5-aminolevulinic acid in malignant glioma surgery in Spain (The VISIONA study)

Ricardo Díez Valle, John Slof, Jordi Galván et al. · Neurología (English Edition) · 2014 · 57 citations · Full text

, , +9

Cost-effectiveness of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery

John Slof, Ricardo Díez Valle, Jordi Galván · Neurología (English Edition) · 2015 · 43 citations · Full text

, , +8

Crossover, double‐blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy

Miguel J. A. Láinez, Jordi Galván, Joan Heras et al. · European Journal of Neurology · 2007 · 40 citations

, , +17

[Almotriptan in the treatment of migraine attacks in clinical practice: results of the TEA 2000 observational study].

Jose Leonard R. Pascual, J M Láinez, Rogelio Leira et al. · PubMed · 2003 · 14 citations

, , +6

1–5 of 6